文献速递关节外科

全髋关节置换术后髂腰肌撞击的非手术治疗与手术治疗结局:系统综述与Meta分析

Outcomes of Nonoperative versus Operative Treatment of Iliopsoas Impingement after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis.
PubMed 文献 · J Arthroplasty · 2025-05-05

该系统综述与Meta分析比较全髋关节置换术后髂腰肌撞击的非手术与手术治疗结局,纳入保守治疗6项研究151例、髂腰肌腱切断术21项研究452例、髋臼翻修5项研究103例。结果显示保守治疗持续症状率53.6%,高于肌腱切断术的17.8%和髋臼翻修的12.6%;肌腱切断术并发症率2.3%,低于髋臼翻修的15.7%。作者认为非手术治疗可能无法提供长期症状缓解,肌腱切断术与髋臼翻修均有效,但肌腱切断术并发症率显著更低。

要点

  • 保守治疗持续髂腰肌撞击症状率53.6%,髂腰肌腱切断术17.8%,髋臼翻修12.6%。
  • 髂腰肌腱切断术并发症率2.3%,髋臼翻修并发症率15.7%。
  • 需再次手术或额外手术干预比例:保守治疗16.4%,髂腰肌腱切断术4.5%,髋臼翻修3.9%。

核心结论

  • 全髋关节置换术后髂腰肌撞击的非手术治疗可能无法提供长期症状缓解。
  • 髂腰肌腱切断术和髋臼翻修均能有效治疗全髋关节置换术后髂腰肌撞击,但肌腱切断术并发症率显著低于髋臼翻修。
  • 讨论持续症状性髂腰肌撞击的手术治疗选择时,充分的患者沟通至关重要。

研究设计与样本

  • 遵循系统综述与Meta分析首选报告条目(PRISMA)指南的系统综述与Meta分析,检索PubMed、Embase和Cochrane Library数据库。
  • 研究按治疗方式分类:保守治疗(皮质类固醇注射)、髂腰肌腱切断术或髋臼翻修。
  • 保守治疗纳入6项研究151例患者,髂腰肌腱切断术纳入21项研究452例患者,髋臼翻修纳入5项研究103例患者。
  • 证据等级为IV级。

主要发现

  • 术前至术后平均Harris髋关节评分:保守治疗组64.8至78.6(P=0.03),髂腰肌腱切断术组54.9至83.1(P<0.00001),髋臼翻修组56至82.4(P<0.00001)。
  • 持续髂腰肌撞击症状发生率:保守治疗组53.6%,髂腰肌腱切断术组17.8%,髋臼翻修组12.6%。
  • 手术治疗并发症率:髂腰肌腱切断术组2.3%,髋臼翻修组15.7%。
  • 需再次手术或额外手术干预比例:保守治疗组16.4%,髂腰肌腱切断术组4.5%,髋臼翻修组3.9%。

关键数值与推荐

  • 保守治疗组术前至术后平均Harris髋关节评分64.8至78.6(P=0.03)。
  • 髂腰肌腱切断术组术前至术后平均Harris髋关节评分54.9至83.1(P<0.00001)。
  • 髋臼翻修组术前至术后平均Harris髋关节评分56至82.4(P<0.00001)。
  • 持续症状率:保守治疗组53.6%,髂腰肌腱切断术组17.8%,髋臼翻修组12.6%。
  • 并发症率:髂腰肌腱切断术组2.3%,髋臼翻修组15.7%;再次手术或额外手术干预比例:保守治疗组16.4%,髂腰肌腱切断术组4.5%,髋臼翻修组3.9%。

临床怎么用

  • 作者认为非手术治疗可能无法提供全髋关节置换术后髂腰肌撞击的长期症状缓解。
  • 作者认为髂腰肌腱切断术和髋臼翻修均能有效治疗全髋关节置换术后髂腰肌撞击,且肌腱切断术并发症率显著低于髋臼翻修。
  • 作者强调讨论持续症状性髂腰肌撞击的手术治疗选择时,充分的患者沟通至关重要。

局限性

  • 证据等级为IV级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Iliopsoas impingement (IPI) is a rare cause of persistent groin pain after primary total hip arthroplasty (THA). Treatment options include conservative management such as corticosteroid injections into the tendon sheath, iliopsoas tenotomy, and acetabular revision. The purpose of this systematic review is to compare outcomes of nonoperative versus operative treatment options for IPI after THA by assessing symptom resolution rate, patient-reported outcomes, complications, and revision surgery rate. METHODS: A systematic review following guidelines established by the Preferred Reporting Items for Systematic Reviews and Meta-analyses was performed in the PubMed, Embase, and Cochrane Library databases regarding IPI after THA. Studies were categorized based on the specific treatment modality: conservative treatment (corticosteroid injections), iliopsoas tenotomy, or acetabular revision. There were six studies (151 patients) that evaluated conservative treatment, 21 studies (452 patients) that evaluated iliopsoas tenotomy, and five studies (103 patients) that evaluated acetabular revision as treatment options for IPI after THA. RESULTS: The mean preoperative to postoperative Harris Hip Scores for the three groups were 64.8 to 78.6 (P = 0.03), 54.9 to 83.1 (P < 0.00001), and 56 to 82.4 (P < 0.00001), respectively. Persistent IPI symptoms were noted in 53.6% (conservative), 17.8% (iliopsoas tenotomy), and 12.6% (acetabular revision) of patients. The complication rate for surgical treatment was 2.3% in the iliopsoas tenotomy group and 15.7% in the acetabular revision group. Revision surgery or additional surgical intervention was required by 16.4% (conservative), 4.5% (iliopsoas tenotomy), and 3.9% (acetabular revision) of patients. CONCLUSIONS: Nonoperative management of IPI after THA may fail to provide long-term resolution of symptoms. While iliopsoas tenotomy and acetabular revision both effectively treat IPI after THA, tenotomy has a significantly lower complication rate compared to acetabular revision. Thorough patient counseling is critical when discussing surgical treatment options for persistent symptomatic IPI after THA. LEVEL OF EVIDENCE: IV.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Razick D, Akhtar M, Sumandea F, et al. Outcomes of Nonoperative versus Operative Treatment of Iliopsoas Impingement after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis. J Arthroplasty. 2025. PMID: 40334954. doi:10.1016/j.arth.2025.04.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。